This article was reviewed by Felix Gussone, MD. Low Testosterone and Joint Pain: What’s the Connection? Your knees, ankles, ...

Verzenio plus endocrine therapy reduced death risk by 15.8% in high-risk early breast cancer patients compared to endocrine ...

An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid ...

Know someone who's been diagnosed with breast cancer? There's a good chance that person has received hormone therapy.

Olema Pharmaceuticals faced a 30% stock drop after ESMO 2025 data on palazestrant, its lead breast cancer candidate. Click ...

Targeting prostate-specific membrane antigen, Lu-PSMA-617 has demonstrated clinical benefits in patients with PSMA-positive ...

Among 804 androgen receptor pathway inhibitor-experienced mCRPC patients, 459 patients (57.1%) received another androgen receptor pathway inhibitor as their index therapy and 192 (23.9%) received ...

Long-term NATALEE data show adjuvant ribociclib plus an aromatase inhibitor improves invasive disease–free survival vs AI ...

Breast cancer recurrence does happen, but thankfully the chance of it is low. Recurrence depends on factors like the type and ...

Two newly approved medications expand options beyond lifestyle modifications for metabolic dysfunction-associated steatotic ...

As Novartis moves ahead plans to expand Pluvicto's use based on the PSMAddition trial, experts urge for greater use of ...